Abstract
Embryonic substantia nigra cells when transplanted into the striatum can reverse many of the defects of Parkinson's disease. The efficacy of such grafts is compromised by the poor survival of grafted dopaminergic neurones; typically, 3–10% survive transplantation. We used three tissue culture models to identify stages in the procedure for the preparation and insertion of grafts which might be responsible for this cell death and to identify environments in which survival is optimised. (1) The ventral mesencephalon was dissected from the donor brain, then placed immediately into culture contained in a collagen gel. (2) The dissected tissue fragments were enzymatically dissociated, then the cells placed into monolayer culture. (3) Enzymatically dissociated tissue was packed into 0.5-mm-diameter porous tubes, to simulate the compaction of cells into a graft deposit in the host brain. Dissociation of the tissue by itself caused the death of approximately 30% of dopaminergic neurones, as judged by the difference in cell counts between the intact embryonic day 14 (E14) mesencephalon, and cells dissociated then packed into tubes. Of the dissociated neurones approximately 60% died during the first 24 h and 87% during the first 3 days in monolayer culture, while only 7% of dopaminergic neurones in three-dimensional cultures and 11% of neurones in explant cultures died over the first 3 days. Embryonic dopaminergic neurones are clearly very vulnerable to adverse conditions during the first days after their removal from the donor brain. The excellent survival of neurones in three-dimensional and explant cultures indicates that close association with other cells, which may provide greatly improved access to trophic factors, can enable the cells to survive this period of vulnerability. In contrast to its effects in monolayer cultures, bFGF had no effect on dopaminergic neuronal survival in either explant or three-dimensional cultures.
Similar content being viewed by others
References
Abercrombie M (1946) Estimation of the nuclear population from microtome sections. Anat Rec 94:239–247
Annett LE, Martel FL, Rogers DC, Ridley RM, Baker HF, Dunnett SB (1994) Behavioural assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostratal pathway. Exp Neurol 125:228–246
Barker RA (1994) Factors important in the survival and functional capacity of intracerebral adrenal and embryonic nigral grafts. PhD thesis, University of Cambridge
Barker RA, Dunnett SB, Fawcett JW (1993) Neurotrophic factors and neural grafts: a growing field. Semin Neurosci 5:431–441
Barker RA, Fricker RA, Abrous DN, Fawcett JW, Dunnett SB (1994) A comparative study of preparation techniques for improving the viability of nigral grafts using vital stains, in vitro cultures and in vivo grafts. Cell Transplant 4:173–200
Beck KD, Knüsel B, Hefti F (1993) The nature of the trophic action of brain-derived neurotrophic factor, des(1–3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience 52:855–866
Berkenbosch F (1992) Macrophages and astroglial interactions in repair to brain injury. Ann NY Acad Sci 650:186–190
Bjorklund A (1993) Better cells for brain repair. Nature 362:414–415
Bolam JP, Freund TF, Bjorklund A, Dunnett SB, Smith AD (1987) Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host neostriatum. Exp Brain Res 68:131–146
Brundin P, Barbin G, Strecker RE, Isacson O, Prochiantz A, Bjorklund A (1988) Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro. Dev Brain Res 39:233–243
Dunnett SB (1991) Transplantation of embryonic dopamine neurons: what we know from rats. J Neurol 238:65–74
Dunnett SB, Bjorklund A, Gage FH, Stenevi U (1985) Transplantation of mesencephalic dopamine neurons to the striatum of adult rats. In: Bjorklund A, Stenevi U (eds) Neural grafting in the mammalian CNS. Elsevier, Amsterdam, pp 451–469
Dunnett SB, Whishaw IQ, Rogers DC, Jones GH (1987) Dopamine-rich grafts ameliorate whole body asymmetry and sensory neglect but not independant limb use in rats with 6-hydroxydopamine lesions. Brain Res 415:63–78
Engele J, Bohn MC (1991) The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J Neurosci 11:3070–3078
Fawcett JW, Housden E, Smith-Thomas L, Meyer RL (1989) The growth of axons in three dimensional astrocyte cultures. Dev Biol 135:449–458
Ferrari G, Minozzi M-C, Toffano G, Leon A, Skaper SD (1989) Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev Biol 133:140–147
Freed CR, et al (1992) Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327:1549–1555
Freed WJ (1994) Substantia nigra grafts and Parkinson's disease: from animal experiments to human therapeutic trials. Restor Neurol Neurosci 3:109–134
Freed WJ, Perlow MJ, Karoum F, Sieger A, Olson L, Hoffer BJ, Wyatt RJ (1980) Restoration of dopaminergic function by grafting of rat substantia nigra to the caudate nucleius: long term behavioural, biochemical and histochemical studies. Ann Neurol 8:510–519
Freund TF, Bolam JP, Bjorklund A, Stenevi U, Dunnett SB, Powell JF, Smith AD (1985) Efferent connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study. J Neurosci 5:603–616
Hedreen JC, Chalmers JP (1972) Neuronal degeneration in rat brain induced by 6-hydroxydopamine: a histological and biochemical study. Brain Res 47:1–30
Hetier E, Ayala J, Denèfle P, Bousseau A, Rouget P, Mallat M, Prochiantz A (1988) Brain macrophages synthesize interleukin-1 and interleukin-1 mRNAs in vitro. J Neurosci Res 21:391–397
Hunt JS, Soares MJ, Lei M-G, Smith RN, Wheaton D, Atherton RA, Morrison DC (1989) Products of lipopolysaccharide-activated macrophages (tumor necrosis factor- α, transforming growth factor- β) but not lipopolysaccharide modify DNA synthesis by rat trophoblast cells exhibiting the 80-kDa lipopolysaccharide-binding protein. J Immunol 143:1606–1613
Hyman C, Hofer M, Barde Y-A, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230–232
Hyman C, Juhasz M, Jackson C, Wright P, Ip NY, Lindsay RM (1994) Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J Neurosci 14:335–347
Janec E, Burke RE (1993) Naturally occurring cell death during postnatal development of the substantia nigra pars compacta of rat. Mol Cell Neurosci 4:30–35
Knusel B, Michel PP, Schwaber JS, Hefti F (1990) Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J Neurosci 10:558–570
Lin L-FH, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130–1132
Lindholm D, Heumann R, Meyer M, Thoenen H (1987) Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 330:658–659
Lindvall O (1991) Prospects of transplantation in human neurodegenerative diseases. Trends Neurosci 14:376–384
Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, Leenders KL, Sawle G, Rothwell JC, Marsden CD, Björklund A (1990) Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574–577
Logan A, Frautschy SA, Gonzalez A-M, Baird A (1992) A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors (flg) following a localized cortical brain injury. J Neurosci 12:3828–3837
Matsuda S, Saito H, Nishiyama N (1990) Effect of basic fibroblast growth factor on neurons cultured from various regions of postnatal rat brain. Brain Res 520:310–316
Mayer E, Dunnett SB, Fawcett JW (1993a) Mitogenic effects of bFGF on embryonic mesencephalic dopaminergic neurones. Dev Brain Res 72:253–258
Mayer E, Fawcett JW, Dunnett SB (1993b) Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons. II. Effects on nigral tranplants in vivo. Neuroscience 56:389–398
Mayer E, Pellitteri R, Dunnett SB, Fawcett JW (1993c) Basic FGF supports the survival of embryonic mesencephalic dopaminergic neurones. I. effects in vitro. Neuroscience 56:379–388
Otto D, Unsicker K (1993) FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells. J Neurosci Res 34:382–393
Perry VH, Gordon S (1991) Macrophages and the nervous system. Int Rev Cytol 125:203–244
Perry VH, Andersson P-B, Gordon S (1993) Macrophages and inflammation in the central nervous system. Trends Neurosci 16:268–273
Redmond DE, Sladek JR, Roth RH, Collier TJ, Elsworth JD, Deutsch AY, Haber S (1986) Foetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet (Lond): 1125–1127
Sauer H, Brundin P (1991) Effect of cool storage on survival and functions of intrastriatal ventral mesencephalic grafts. Restor Neurol Neurosci 2:123–135
Sauer H, Fischer W, Nikkhah G, Wiegand SJ, Brundin P, Lindsay RM, Bjorklund A (1993) Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res 626:37–44
Steinbusch HWM, Vermuelen RJ, Tonnaer ADM (1990) Basic fibroblast growth factor enhances survival and sprouting of fetal dopaminergic cells implanted in the denervated rat caudate-putamery: preliminary observations. Prog Brain Res 82:81–86
Stromberg I, Bjorklund L, Johansson M, Tomac A, Collins F, Olson L, Hoffer B, Humpel C (1993) Glial cell-derived neurotrophic factor is expressed in the developing but not adult striaturn and stimulates developing dopamine neurons in vivo. Exp Neurol 124:401–412
Swanson LW (1982) The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull 9:321–353
Tessier-Lavigne M, Placzek M, Lumsden AGS, Dodd J, Jessell TM (1988) Chemotropic guidance of developing axons in the mammalian central nervous system. Nature 336:775–778
Unsicker K, Reichert-Preibsch H, Wewetzer K (1992) Stimulation of neuron survival by basic FGF and CNTF is a direct effect and not mediated by non-neuronal cells: evidence from single cell cultures. Dev Brain Res 65:285–288
Widner H, Tetrud J, Rehncrona S, Snow B, Brundin P, Gustavii B, Bjorklund A, Lindvall O, Langston JW (1992) Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 26:1556–1563
Yoshida K, Gage FH (1991) Fibroblast growth factors stimulate nerve growth factor synthesis and secretion by astrocytes. Brain Res 538:118–126
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fawcett, J.W., Barker, R.A. & Dunnett, S.B. Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon. Exp Brain Res 106, 275–282 (1995). https://doi.org/10.1007/BF00241123
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00241123